Cresco Labs (CRLBF) Other Working Capital Changes (2020 - 2026)
Cresco Labs (CRLBF) posted Other Working Capital Changes of -$2.3 million for Q1 2026, down 3.2% on a QoQ basis from -$2.2 million in Q4 2025, and up 14.93% year-over-year from -$2.0 million in Q1 2025.
Cresco Labs (CRLBF) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Cresco Labs' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 14.93% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.1 million (down 4.25% YoY) and the FY2025 annual result came in at -$9.5 million, down 19.68% from the prior year.
- Other Working Capital Changes was -$2.3 million for Q1 2026 at Cresco Labs, down from -$2.2 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $12.3 million in Q4 2025 and bottomed at -$6.1 million in Q2 2022.
- A 5-year average of -$447411.8 and a median of $119000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 141.49% — and 2024, when it surged 72.6%.
- Cresco Labs' Other Working Capital Changes stood at $17.1 million in 2022, then sank by 141.49% to -$7.1 million in 2023, then surged by 70.29% to -$2.1 million in 2024, then declined by 5.17% to -$2.2 million in 2025, then fell by 3.2% to -$2.3 million in 2026.
- Business Quant data shows CRLBF's Other Working Capital Changes at -$2.3 million in Q1 2026, -$2.2 million in Q4 2025, and -$2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.79 Mn |
| Mar 31, 2026 | -5.79 Mn |
| Mar 31, 2026 | -5.79 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Sep 30, 2025 | 822,000.00 |
| Sep 30, 2025 | 822,000.00 |
| Sep 30, 2025 | 822,000.00 |
| Jun 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.22 Mn |
| Jun 30, 2025 | -1.22 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Sep 30, 2024 | 119,000.00 |
| Sep 30, 2024 | 119,000.00 |